Pravastatin cost effective for preventing atherosclerotic CVD in people with HIV

Source: PharmacoEconomics and Outcomes News - Category: Drugs & Pharmacology Source Type: news

Related Links:

STATINS side effects can include muscle pain, diarrhoea or headaches. Certain foods or drinks consumed may increase your risk of statin side effects.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Conclusion: Patients with psoriasis have a higher atherosclerotic burden as quantified by CT-LeSc and less coronary inflammation as detected by perivascular FAI around the most proximal of the three major epicardial vessels. The usefulness of perivascular FAI for evaluating coronary inflammation in patients with chronic low-grade inflammatory disease such as psoriasis should be verified.Dermatology
Source: Dermatology - Category: Dermatology Source Type: research
CONCLUSIONS: Herein, the extant evidence for the potential value of statins in targeting pyroptosis in various diseases is reviewed.PMID:34522271 | PMC:PMC8425236 | DOI:10.5114/aoms/141155
Source: Archives of Medical Science - Category: Biomedical Science Authors: Source Type: research
ConclusionsStatin use in patients hospitalized with COVID-19 was associated with a reduced in-hospital mortality. The protective effect of statin was greater in those with coronary artery disease. These data support continued use of statin therapy in hospitalized patients with COVID-19. Clinical trials are needed to prospectively determine if statin use is effective in lowering the mortality in COVID-19 and other viral infections.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
CONCLUSIONS: This study suggests that there are differences in the diabetogenic effect of statins. Simvastatin and high doses of atorvastatin may be associated with greater impairment in glucose metabolism than pitavastatin and other statins with less lipid-lowering potency such as pravastatin.PMID:34517987 | DOI:10.1016/j.medcli.2021.06.018
Source: Medicina Clinica - Category: General Medicine Authors: Source Type: research
Br J Radiol. 2021 Sep 14:20210361. doi: 10.1259/bjr.20210361. Online ahead of print.ABSTRACTOBJECTIVES: Previous studies reported the association between inflammation and atrial fibrillation (AF). Pericoronary adipose tissue (PCAT) attenuation, PCATA, on cardiac CT angiography (CTA) reflects pericoronary inflammation. We hypothesized that the PCATA predicts AF recurrence after cryoballoon ablation (CBA) for paroxysmal and persistent AF.METHODS: We studied 364 patients (median age, 65 years) with persistent (n = 41) and paroxysmal (n = 323) AF undergoing successful first-session second-generation CBA with pre-ablation cardi...
Source: The British Journal of Radiology - Category: Radiology Authors: Source Type: research
CONCLUSIONS: LDL-C control is suboptimal and the available LLT armamentarium, most importantly combination therapy, is being underutilized in high/very high risk patients leading to inadequate management of cardiovascular risk.PMID:34517739 | DOI:10.1080/03007995.2021.1973396
Source: Current Medical Research and Opinion - Category: Research Authors: Source Type: research
This study population consists of 100 patients with stable CAD who will undergo PCI and have high low-density lipoprotein cholesterol levels despite administration of maximum tolerated dose of statins for at least 2 weeks. Eligible patients are randomized in a 1:1 ratio to receive either evolocumab 140 mg every 2 weeks in addition to standard of care treatment or standard of care treatment only for 2-6 weeks before PCI. The primary endpoint is IMR after PCI. The EVOCATION trial will evaluate whether pretreatment with evolocumab reduces periprocedural microvascular damage in patients with stable CAD undergoing PCI.PMID:3451...
Source: Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Clin Ther. 2021 Sep 10:S0149-2918(21)00302-7. doi: 10.1016/j.clinthera.2021.08.005. Online ahead of print.ABSTRACTPURPOSE: Residual cardiovascular risk reduction by fenofibrate in patients with high serum triglyceride (TG) levels despite previous statin monotherapy is not well characterized. The purpose of this study was to evaluate the efficacy and safety of a combination of choline fenofibrate and statin in patients with inadequately controlled TG levels despite previous statin monotherapy.METHODS: This prospective, multicenter, randomized, double-blind study was conducted in Korea. A total of 133 patients with controlle...
Source: Clinical Therapeutics - Category: Drugs & Pharmacology Authors: Source Type: research
Review of the US and European literature indicates that most patients at high risk for atherosclerotic cardiovascular disease (ASCVD are not treated with high-intensity statins, despite strong clinical-trial evidence of maximal statin benefit. High-intensity statins are recommended for 2 categories of patients: those with ASCVD (secondary prevention) and high-risk patients without clinical ASCVD. Most patients with ASCVD are candidates for high-intensity statins, with a goal for low-density lipoprotein cholesterol reduction of 50% or greater.
Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Tags: Consensus recommendation Source Type: research
More News: Drugs & Pharmacology | Pravastatin | Statin Therapy